中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2011年
1期
6-9
,共4页
孙文洁%於海军%熊杰%徐禹%廖正凯%周福祥%谢从华%周云峰
孫文潔%於海軍%熊傑%徐禹%廖正凱%週福祥%謝從華%週雲峰
손문길%어해군%웅걸%서우%료정개%주복상%사종화%주운봉
基因放射治疗%肝癌%腺病毒%人端粒酶反转录酶%嵌合启动子
基因放射治療%肝癌%腺病毒%人耑粒酶反轉錄酶%嵌閤啟動子
기인방사치료%간암%선병독%인단립매반전록매%감합계동자
Gene-radiotherapy%Hepatocellular carcinoma%Adenovirus%Human telomerase reverse transcriptase%Chimeric promoter
目的 检测利用肿瘤特异性辐射诱导嵌合启动子介导的腺病毒自杀基因系统联合放射线对肝癌细胞裸鼠皮下移植瘤生长的抑制作用.方法 构建含有6个串联放射反应元件的人端粒酶反转录酶基因嵌合启动子调控辣根过氧化物酶表达的复制缺陷型腺病毒,同时建立人肝癌细胞MHCC97裸鼠皮下移植瘤模型,瘤内注射重组腺病毒,腹腔注射吲哚乙酸,同时给予γ射线照射,观察肿瘤生长、裸鼠生存状态,以及肿瘤组织和正常器官的组织病理学改变.结果 分组处理后第31天,阴性对照病毒组、单纯病毒组、单纯照射组及联合组裸鼠皮下移植瘤相对体积分别为49.23±4.55、27.7l±7.74、28.53±10.48和.11.58±3.23,组间差异具有统计学意义(F=16.288,P<0.01),其中联合组的肿瘤抑制作用最强,生长抑制率为76.5%;与对照组相比,非对照组均能延长裸鼠中位生存期(x2=18.307,P<0.01),其中联合组差异最显著(13 d与43 d);光镜下各治疗组肿瘤组织均出现坏死,其中联合组肿瘤坏死较多,而正常器官组织病理学检查未发现治疗相关损伤改变.对照组裸鼠肝脏显示出密集的肝癌转移灶,单纯治疗组仅有少数转移灶,而联合组肝脏未见明显异常.结论 复制缺陷型腺病毒介导的靶向自杀基因治疗联合放疗能有效抑制肝癌皮下移植瘤生长,延长裸鼠生存期,为肝癌的治疗提供了新的途径,具有良好的应用前景.
目的 檢測利用腫瘤特異性輻射誘導嵌閤啟動子介導的腺病毒自殺基因繫統聯閤放射線對肝癌細胞裸鼠皮下移植瘤生長的抑製作用.方法 構建含有6箇串聯放射反應元件的人耑粒酶反轉錄酶基因嵌閤啟動子調控辣根過氧化物酶錶達的複製缺陷型腺病毒,同時建立人肝癌細胞MHCC97裸鼠皮下移植瘤模型,瘤內註射重組腺病毒,腹腔註射吲哚乙痠,同時給予γ射線照射,觀察腫瘤生長、裸鼠生存狀態,以及腫瘤組織和正常器官的組織病理學改變.結果 分組處理後第31天,陰性對照病毒組、單純病毒組、單純照射組及聯閤組裸鼠皮下移植瘤相對體積分彆為49.23±4.55、27.7l±7.74、28.53±10.48和.11.58±3.23,組間差異具有統計學意義(F=16.288,P<0.01),其中聯閤組的腫瘤抑製作用最彊,生長抑製率為76.5%;與對照組相比,非對照組均能延長裸鼠中位生存期(x2=18.307,P<0.01),其中聯閤組差異最顯著(13 d與43 d);光鏡下各治療組腫瘤組織均齣現壞死,其中聯閤組腫瘤壞死較多,而正常器官組織病理學檢查未髮現治療相關損傷改變.對照組裸鼠肝髒顯示齣密集的肝癌轉移竈,單純治療組僅有少數轉移竈,而聯閤組肝髒未見明顯異常.結論 複製缺陷型腺病毒介導的靶嚮自殺基因治療聯閤放療能有效抑製肝癌皮下移植瘤生長,延長裸鼠生存期,為肝癌的治療提供瞭新的途徑,具有良好的應用前景.
목적 검측이용종류특이성복사유도감합계동자개도적선병독자살기인계통연합방사선대간암세포라서피하이식류생장적억제작용.방법 구건함유6개천련방사반응원건적인단립매반전록매기인감합계동자조공랄근과양화물매표체적복제결함형선병독,동시건립인간암세포MHCC97라서피하이식류모형,류내주사중조선병독,복강주사신타을산,동시급여γ사선조사,관찰종류생장、라서생존상태,이급종류조직화정상기관적조직병이학개변.결과 분조처리후제31천,음성대조병독조、단순병독조、단순조사조급연합조라서피하이식류상대체적분별위49.23±4.55、27.7l±7.74、28.53±10.48화.11.58±3.23,조간차이구유통계학의의(F=16.288,P<0.01),기중연합조적종류억제작용최강,생장억제솔위76.5%;여대조조상비,비대조조균능연장라서중위생존기(x2=18.307,P<0.01),기중연합조차이최현저(13 d여43 d);광경하각치료조종류조직균출현배사,기중연합조종류배사교다,이정상기관조직병이학검사미발현치료상관손상개변.대조조라서간장현시출밀집적간암전이조,단순치료조부유소수전이조,이연합조간장미견명현이상.결론 복제결함형선병독개도적파향자살기인치료연합방료능유효억제간암피하이식류생장,연장라서생존기,위간암적치료제공료신적도경,구유량호적응용전경.
Objective To detect the selective inhibitory effects of irradiation plus adenovirusmediated horseradish peroxidase ( HRP)/indole-3-acetic acid (IAA) suicide gene system using tumorspecific and radio-inducible chimeric promoter on human hepatocellular carcinoma subcutaneously xenografted in nude mouse.MethodsRecombinant replicated-deficient adenovirus vector containing HRP gene and chimeric human telomerase reverse transcriptase (hTERT) promoter carrying 6 radioinducible CArG elements was constructed.A human subcutaneous transplanting hepatocellular carcinoma (MHCC97 cell line) model was treated with -γ-ray irradiation plus intra-tumor injections of adenoviral vector and intra-peritoneal injections of prodrug IAA.The change of tumor volume and tumor growth inhibiting rate,the survival time of nude mice,as well as histopathology of xenograft tumor and normal tissues were evaluated.Results Thirty one days after the treatment,the relative tumor volumes in the negative,adenovirus therapy,irradiation,and combination groups were 49.23 ± 4.55,27.71 :± 7.74,28.53 + 10.48 and 11.58 ± 3.23,respectively.There was a significantly statistical difference among them (F = 16.288,P <0.01 ).The inhibition effect in the combination group was strongest as compared with that in other groups,and its inhibition ratio was 76.5%.The survival period extended to 43 d in the combination group,which showed a significantly difference with that in the control group(x2 = 18.307 ,P <0.01 ).The area of tumors necrosis in the combination group was larger than that in the other groups,and the normal tissues showed no treatment-related toxic effect in all groups.However,multiple hepatocellular carcinoma metastases were observed in the liver in the control group,there were a few metastases in the monotherapy groups and no metastasis in the combination group.Conclusions Adenovirus-mediated suicide gene therapy plus radiotherapy dramatically could inhibit tumor growth and prolong median survival time.It might provide a promising therapeutic modality for hepatocellular carcinoma therapy.